Skip to content

Company

S32

California venture capital firm founded by Bill Maris, who started GV (formerly Google Ventures); it invests in AI, biotech and science-driven companies.

Known aliases

  • S32 venture capital

Current stories

buildOne report1 publisher

Snorkel's $3.5bn price rests on an unaudited run-rate that grew 17.5 times in a year

Insight Partners and S32 led $350 million into a business that ships graded tasks, rubrics and reinforcement-learning environments to frontier labs. The price works out near ten times a company-reported run-rate.

Reality

Evidence50
Adoption55
Hype gap+25
Incentives60
Confidence55
investConfirmed3 publishers

Snorkel sells about a tenth of itself for $350 million at a $3.5 billion valuation

Insight Partners and S32 co-led the round, and the product they are funding is expert-built agentic environments and rubrics that Snorkel says take qualified humans hours or days to construct.

Perspective Coverage

3 publishers
Builder
Builder 23%
Operator
Operator 17%
Investor
Investor 60%

Reality

Evidence55
Adoption40
Hype gap+25
Incentives70
Confidence60
investConfirmed3 publishers

Basecamp Research raises more in one round than in its first seven years combined

S32 led a $140M round that takes Basecamp Research's total funding to $225M since 2019. Two of the sixteen named backers, NVIDIA and Anthropic's Anthology Fund, are also partners on the dataset its models train on.

Perspective Coverage

3 publishers
Builder
Builder 30%
Operator
Operator 15%
Investor
Investor 55%

Reality

Evidence55
Adoption
Not scored
Hype gap+40
Incentives75
Confidence60
investOne report1 publisher

S32 leads $140 million round for Basecamp Research's DNA from a million unsequenced species

The Series C values Basecamp Research at about $800 million, roughly 3.6 times everything it has raised, on the strength of a proprietary sequence library and scaling comparisons the company ran internally.

Publishers:techtimes.com

Reality

Evidence30
Adoption15
Hype gap+38
Incentives78
Confidence45
productOne report1 publisher

Basecamp banks $140M on a gene atlas it built with Anthropic and Nvidia

The Series C funds a 28-billion-parameter model trained on more than 100 billion genes. Two of the partners who helped assemble that dataset, Nvidia and Anthropic's joint fund, are also in the round.

Publishers:siliconangle.com

Reality

Evidence28
Adoption
Not scored
Hype gap+34
Incentives72
Confidence48
leadershipOne report1 publisher

Snorkel's $3.5bn round prices the company at about nine times its claimed run rate

Insight Partners and S32 co-led $350m at a valuation nearly 2.7 times the one Snorkel took in May 2025. The $375m figure underneath it is an annualized run rate, and the company's own launch dates for the service that produced it do not agree.

Publishers:implicator.ai

Reality

Evidence40
Adoption30
Hype gap+35
Incentives80
Confidence55
investOne report1 publisher

Merck's health innovation fund co-leads $37.3M for machine-readable clinical trial design

Faro says six of the ten largest drugmakers already use its platform to design studies. The eight investors on its Series B are each putting in about $4.7 million to find out what that adoption converts into.

Publishers:thesaasnews.com

Reality

Evidence24
Adoption27
Hype gap+36
Incentives74
Confidence32
investOne report1 publisher

Agents climbed from 3% to 50% of the work created in Linear in four quarters

Linear's $99m tender at a $2.5bn mark prices existing shares rather than new capital, while the blog beneath it puts agent-created work at half the total, a composition figure Atlassian answers with a 4x quarter off an undisclosed base.

Publishers:saastr.com

Reality

Evidence58
Adoption68
Hype gap+20
Incentives78
Confidence55
buildOne report1 publisher

Merck co-leads $37.3M into Faro's bet that clinical agents need a schema first

Eight investors are named on the round and no valuation was disclosed. The only outside corroboration of Faro's data model covers how it writes protocols, not what agents do with them.

Publishers:runtimewire.com

Reality

Evidence44
Adoption31
Hype gap+28
Incentives72
Confidence48